Total Payments
$2,373
2024 Payments
$694.81
Companies
19
Transactions
109
Medicare Patients
1,340
Medicare Billing
$101,603
Payment Breakdown by Category
Food & Beverage$2,373 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,373 | 109 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $415.49 | 22 | $0 (2024) |
| CSL Behring | $297.29 | 15 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $237.60 | 13 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $195.89 | 7 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $182.10 | 6 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $176.58 | 8 | $0 (2024) |
| GENZYME CORPORATION | $141.48 | 7 | $0 (2024) |
| Stryker Corporation | $137.35 | 1 | $0 (2021) |
| Optinose US, Inc. | $133.39 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $110.28 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $694.81 | 33 | GlaxoSmithKline, LLC. ($139.78) |
| 2023 | $766.39 | 37 | CSL Behring ($145.86) |
| 2022 | $620.67 | 29 | GlaxoSmithKline, LLC. ($134.00) |
| 2021 | $291.09 | 10 | Stryker Corporation ($137.35) |
All Payment Transactions
109 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $34.68 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.55 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: NEUROLOGY | ||||||
| 12/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/13/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: NEUROLOGY | ||||||
| 10/24/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $32.71 | General |
| Category: Narcoplepsy | ||||||
| 10/17/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Immunology | ||||||
| 10/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Immunology | ||||||
| 10/15/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: RESPIRATORY | ||||||
| 09/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Immunology | ||||||
| 09/11/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $26.56 | General |
| Category: Narcoplepsy | ||||||
| 09/03/2024 | kaleo, Inc. | AUVI-Q (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Allergy | ||||||
| 08/08/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Immunology | ||||||
| 07/30/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: IMMUNOLOGY | ||||||
| 07/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: IMMUNOLOGY | ||||||
| 07/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $1.67 | General |
| Category: IMMUNOLOGY | ||||||
| 07/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.17 | General |
| Category: Immunology | ||||||
| 07/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: RESPIRATORY | ||||||
| 06/20/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: NEUROLOGY | ||||||
| 06/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: RESPIRATORY | ||||||
| 05/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT, DUPIXENT | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 620 | 698 | $166,268 | $46,133 |
| 2022 | 9 | 489 | 515 | $116,964 | $36,699 |
| 2021 | 5 | 124 | 126 | $112,168 | $10,212 |
| 2020 | 3 | 107 | 109 | $117,469 | $8,559 |
Total Patients
1,340
Total Services
1,448
Medicare Billing
$101,603
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 135 | 148 | $59,200 | $15,040 | 25.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 120 | 125 | $27,549 | $9,275 | 33.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 120 | 147 | $24,997 | $8,063 | 32.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 56 | 56 | $11,348 | $3,502 | 30.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $10,474 | $3,410 | 32.6% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2023 | 35 | 39 | $13,650 | $2,967 | 21.7% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 68 | 91 | $12,000 | $2,172 | 18.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 36 | 42 | $5,250 | $1,311 | 25.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 12 | 12 | $1,800 | $393.11 | 21.8% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 84 | 90 | $36,000 | $10,266 | 28.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 71 | 77 | $17,422 | $6,481 | 37.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 109 | 118 | $20,650 | $6,449 | 31.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 54 | 54 | $10,800 | $3,792 | 35.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $6,325 | $2,347 | 37.1% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2022 | 24 | 25 | $8,750 | $2,179 | 24.9% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 49 | 53 | $6,850 | $1,400 | 20.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 18 | 18 | $2,898 | $1,291 | 44.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 26 | 26 | $3,094 | $1,233 | 39.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 19 | 19 | $2,375 | $679.26 | 28.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 12 | 12 | $1,800 | $582.84 | 32.4% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 40 | 41 | $62,156 | $5,076 | 8.2% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 21 | 21 | $21,546 | $1,815 | 8.4% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 35 | 36 | $24,588 | $1,682 | 6.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 13 | 13 | $2,093 | $843.64 | 40.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 15 | 15 | $1,785 | $795.21 | 44.5% |
About Jenna Locaputo, PA-C
Jenna Locaputo, PA-C is a Medical healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/26/2013. The National Provider Identifier (NPI) number assigned to this provider is 1740614890.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jenna Locaputo, PA-C has received a total of $2,373 in payments from pharmaceutical and medical device companies, with $694.81 received in 2024. These payments were reported across 109 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,373).
As a Medicare-enrolled provider, Locaputo has provided services to 1,340 Medicare beneficiaries, totaling 1,448 services with total Medicare billing of $101,603. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Location Albany, NY
- Active Since 08/26/2013
- Last Updated 08/16/2021
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1740614890
Products in Payments
- DUPIXENT (Biological) $379.08
- NUCALA (Biological) $259.69
- Hizentra (Biological) $255.76
- CUVITRU (Biological) $195.89
- TRELEGY ELLIPTA (Drug) $155.80
- WAKIX (Drug) $149.24
- XYWAV (Drug) $137.39
- XPRESS ENT DILATION SYSTEM (Device) $137.35
- Xhance (Drug) $133.39
- TEZSPIRE (Biological) $69.88
- AUVI-Q (Drug) $65.47
- Sunosi (Drug) $63.70
- Haegarda (Biological) $41.53
- SUNOSI (Drug) $39.19
- PRE-PEN (Drug) $33.46
- Wakix (Drug) $32.86
- SINUVA (Drug) $29.60
- RUCONEST (Biological) $28.58
- Odactra (Drug) $25.00
- AYVAKIT (Drug) $22.84
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Albany
Ms. Rebecca Ellwood, Pa-C, PA-C
Medical — Payments: $403,764
Medical $403,764
Brianna Samson, Pa-C, PA-C
Medical — Payments: $4,331
Medical $4,331
Murtaza Singaporewala, Pa, PA
Medical — Payments: $2,743
Medical $2,743
Peter Schuman, Rpa-C, RPA-C
Medical — Payments: $2,701
Medical $2,701
John Dennis, Pa-C, PA-C
Medical — Payments: $2,518
Medical $2,518
Erin Bethon, Pa, PA
Medical — Payments: $2,451
Medical $2,451